ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1028
-0,53%
Bitcoin
66.866,14
2,49%
Brent Oil
83,73
0,63%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Molecular Templates Inc (MTEM)

  7. Molecular Templates Inc (MTEM) Notícias

MTEM

Molecular Templates (MTEM)

Molecular Templates Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MTEM
DataHoraFonteTítuloCódigoCompanhia
15/05/202418:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MTEMMolecular Templates Inc
15/05/202418:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MTEMMolecular Templates Inc
15/05/202418:11GlobeNewswire Inc.Molecular Templates, Inc. Reports First Quarter 2024 Financial Results and Corporate UpdateNASDAQ:MTEMMolecular Templates Inc
09/04/202409:11GlobeNewswire Inc.Molecular Templates Presents Interim Data from MT-6402 Phase I Study in Patients with PD-L1+ Solid Tumors at the 2024 American Association for Cancer Research (AACR) Annual Meeting; Monotherapy Activity in Checkpoint-Experienced Head and Neck Cancer PatienNASDAQ:MTEMMolecular Templates Inc
29/03/202409:21GlobeNewswire Inc.Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
28/03/202409:11GlobeNewswire Inc.Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase AgreementNASDAQ:MTEMMolecular Templates Inc
04/03/202410:11GlobeNewswire Inc.Molecular Templates, Inc. Provides Interim UpdateNASDAQ:MTEMMolecular Templates Inc
14/02/202422:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MTEMMolecular Templates Inc
14/02/202418:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MTEMMolecular Templates Inc
08/02/202419:55GlobeNewswire Inc.Molecular Templates to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:MTEMMolecular Templates Inc
25/01/202419:49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
13/11/202318:11GlobeNewswire Inc.Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
02/11/202317:11GlobeNewswire Inc.Molecular Templates Announces First Patient Dosed in Phase 1 Trial Evaluating MT-8421, a Novel Engineered Toxin Body Targeting CTLA-4, in Advanced Solid TumorsNASDAQ:MTEMMolecular Templates Inc
01/11/202317:12GlobeNewswire Inc.Molecular Templates to Participate in Upcoming Investor ConferencesNASDAQ:MTEMMolecular Templates Inc
06/10/202318:08Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MTEMMolecular Templates Inc
28/09/202317:11GlobeNewswire Inc.Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical OfficerNASDAQ:MTEMMolecular Templates Inc
12/09/202318:15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MTEMMolecular Templates Inc
12/09/202318:12Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MTEMMolecular Templates Inc
12/09/202318:08Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MTEMMolecular Templates Inc
21/08/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MTEMMolecular Templates Inc
11/08/202312:22GlobeNewswire Inc.Molecular Templates Announces 1-for-15 Reverse Stock SplitNASDAQ:MTEMMolecular Templates Inc
10/08/202310:01Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MTEMMolecular Templates Inc
10/08/202309:08GlobeNewswire Inc.Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business UpdateNASDAQ:MTEMMolecular Templates Inc
02/08/202317:11GlobeNewswire Inc.Molecular Templates Announces Executive Leadership ChangesNASDAQ:MTEMMolecular Templates Inc
31/07/202317:28Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:MTEMMolecular Templates Inc
13/07/202309:14GlobeNewswire Inc.Molecular Templates Announces Up to $40 Million Private Placement OfferingNASDAQ:MTEMMolecular Templates Inc
30/06/202317:31Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:MTEMMolecular Templates Inc
26/06/202318:28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:MTEMMolecular Templates Inc
20/06/202308:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTEMMolecular Templates Inc
16/06/202321:56GlobeNewswire Inc.Molecular Templates Announces Debt Payoff and RestructuringNASDAQ:MTEMMolecular Templates Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:MTEM

Seu Histórico Recente

BIT
TRS5
SSgA SPDR ETFs Europe I ...
NASDAQ
BRSH
Bruush Oral Care
EU
FR001400P8C5
Tisseo Collectivities Ti...
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados